Abstract
Little is understood about the relationship between glycated haemoglobin and future functional health in the general population. In this work, we aimed to assess if glycaemic control is associated with future physical and mental functional health at 18-month follow-up in a UK general population, in those with and without diabetes. This work was a cross-sectional study. Between 1995 and 1997, participants of the European Prospective Investigation into Cancer, Norfolk, attended a health check including blood testing for haemoglobin A1c (HbA1c) and completed a health and lifestyle questionnaire. Eighteen months later, self-reported physical and mental functional health were assessed using short form-36 (SF-36). Outcomes of interest included physical and mental component summary (PCS and MCS, respectively) scores of the SF-36. A total of 7343 participants (56% women, mean (SD) 58.1 ± 9.5 years) were eligible to be included, of whom 167 had prevalent diabetes. In our linear regression analysis, a higher HbA1c (mmol/mol) was found to be associated with a poorer PCS score (coefficient −0.15 (p < 0.0001)) at follow-up. After adjustment for comorbid conditions, including obesity, this association was no longer statistically significant. A higher HbA1c (mmol/mol) was associated with a better MCS score at follow-up; this finding was significant when adjusted for comorbid conditions (coefficient 0.029 (p < 0.05)). Our findings suggest that the association between a higher HbA1c and poorer physical functional health is explained by a higher BMI and comorbidity status in a general population. While higher HbA1c was found to be associated with higher mental functional health at follow-up, the magnitude of this association was small. Healthy responder bias and unmeasured confounding variables may have influenced this result; thus, it should be interpreted with caution.
Original language | English |
---|---|
Article number | 1336 |
Number of pages | 9 |
Journal | Journal of Personalized Medicine |
Volume | 13 |
Issue number | 9 |
Early online date | 30 Aug 2023 |
DOIs | |
Publication status | Published - 30 Aug 2023 |
Bibliographical note
FundingThe EPIC-Norfolk study (DOI 10.22025/2019.10.105.00004) has received funding from the Medical Research Council (grant number MR/N003284/1 and MC-UU_12015/1) and Cancer Research UK (grant number C864/A14136).
Acknowledgments
We are grateful to the participants of the EPIC-Norfolk study who have been part of this project, and to the many members of the study teams at the University of Cambridge who have enabled this research. We gratefully acknowledge the EPIC management committee for their approval for data use for this study.
Data Availability Statement
Data are available upon request, with applications made to the EPIC-Norfolk steering committee for consideration.Keywords
- diabetes
- health-related quality of life
- epidemiology
- functional health
- glycated haemoglobin